India’s Jubilant, France’s Guerbet In Device Distribution Deal In Europe
This article was originally published in PharmAsia News
Jubilant Organosys of India and France's Guerbet have signed an agreement to have the French firm distribute Jubilant's nuclear-medicine products in Europe. Jubilant's diagnostic and therapy imaging devices are intended to complement MRI and X-ray scans. The head of Jubilant said the deal enables it to expand its business in regulated markets while gaining a greater market share in Europe. The deal was made through Jubilant's subsidiary, Draximage. (Click here for more
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.